Capital Market Strategies LLC Increases Holdings in Axon Enterprise, Inc. (NASDAQ:AXON)

Capital Market Strategies LLC increased its position in Axon Enterprise, Inc. (NASDAQ:AXON) by 1.0% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 2,826 shares of the biotechnology company’s stock after acquiring an additional 29 shares during the period. Axon Enterprise comprises approximately 1.0% of Capital Market Strategies LLC’s holdings, making the stock its 20th largest position. Capital Market Strategies LLC’s holdings in Axon Enterprise were worth $1,680,000 at the end of the most recent quarter.

Several other hedge funds have also recently modified their holdings of the business. Insigneo Advisory Services LLC raised its holdings in shares of Axon Enterprise by 1.4% during the third quarter. Insigneo Advisory Services LLC now owns 1,568 shares of the biotechnology company’s stock valued at $627,000 after purchasing an additional 22 shares during the last quarter. Menard Financial Group LLC grew its position in shares of Axon Enterprise by 0.8% during the third quarter. Menard Financial Group LLC now owns 3,014 shares of the biotechnology company’s stock worth $1,204,000 after purchasing an additional 24 shares in the last quarter. PFG Investments LLC lifted its holdings in shares of Axon Enterprise by 0.6% in the third quarter. PFG Investments LLC now owns 3,872 shares of the biotechnology company’s stock worth $1,547,000 after buying an additional 25 shares in the last quarter. Gladstone Institutional Advisory LLC increased its stake in Axon Enterprise by 1.6% in the 3rd quarter. Gladstone Institutional Advisory LLC now owns 1,641 shares of the biotechnology company’s stock worth $656,000 after acquiring an additional 26 shares during the last quarter. Finally, Mather Group LLC. raised its position in shares of Axon Enterprise by 3.7% during the 3rd quarter. Mather Group LLC. now owns 759 shares of the biotechnology company’s stock valued at $303,000 after buying an additional 27 shares in the last quarter. Hedge funds and other institutional investors own 79.08% of the company’s stock.

Insider Transactions at Axon Enterprise

In other Axon Enterprise news, Director Caitlin Elizabeth Kalinowski sold 450 shares of the business’s stock in a transaction that occurred on Thursday, January 2nd. The stock was sold at an average price of $604.07, for a total transaction of $271,831.50. Following the completion of the sale, the director now directly owns 6,929 shares in the company, valued at approximately $4,185,601.03. The trade was a 6.10 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Jeffrey C. Kunins sold 1,035 shares of Axon Enterprise stock in a transaction on Monday, December 23rd. The stock was sold at an average price of $624.47, for a total value of $646,326.45. Following the transaction, the insider now owns 124,243 shares in the company, valued at approximately $77,586,026.21. This represents a 0.83 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 51,545 shares of company stock valued at $31,159,317 in the last 90 days. 6.10% of the stock is currently owned by company insiders.

Wall Street Analysts Forecast Growth

A number of analysts recently issued reports on the company. Needham & Company LLC raised their price target on Axon Enterprise from $525.00 to $600.00 and gave the stock a “buy” rating in a research report on Friday, November 8th. JMP Securities increased their price objective on shares of Axon Enterprise from $430.00 to $500.00 and gave the stock a “market outperform” rating in a research report on Thursday, October 31st. Robert W. Baird boosted their target price on Axon Enterprise from $600.00 to $800.00 and gave the company an “outperform” rating in a research report on Friday, December 6th. The Goldman Sachs Group increased their price target on Axon Enterprise from $385.00 to $441.00 and gave the stock a “buy” rating in a report on Wednesday, October 23rd. Finally, Morgan Stanley upgraded Axon Enterprise from an “equal weight” rating to an “overweight” rating and boosted their price objective for the company from $500.00 to $700.00 in a report on Tuesday, December 3rd. One investment analyst has rated the stock with a hold rating and thirteen have given a buy rating to the company’s stock. According to data from MarketBeat, Axon Enterprise has an average rating of “Moderate Buy” and an average price target of $488.67.

Axon Enterprise Stock Performance

Shares of NASDAQ:AXON traded down $37.62 on Monday, hitting $563.44. 1,007,622 shares of the company were exchanged, compared to its average volume of 646,014. The company has a current ratio of 2.96, a quick ratio of 2.63 and a debt-to-equity ratio of 0.32. Axon Enterprise, Inc. has a 1-year low of $244.01 and a 1-year high of $698.67. The firm has a market capitalization of $42.97 billion, a P/E ratio of 145.59, a price-to-earnings-growth ratio of 14.19 and a beta of 1.04. The stock’s 50 day moving average price is $593.68 and its 200 day moving average price is $441.20.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.